Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer, including KRAS and Her2

Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations

Joshua R. Veatch, Brenda Jesernig, Julia Kargl, et al. (2019). Cancer Immunology Research. Cited 80 times. https://doi.org/10.1158/2326-6066.CIR-18-0402